Latest in Endocrinology
Reuters Health • The Doctor's Channel Daily Newscast
Metformin may prevent liver cancer in type 2 diabetes
1:22 |
May 9, 2012
|
Diabetes, Endocrinology, Family Medicine, Internal Medicine, Nurses/NP/PA, Oncology, Pharmacists, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – Metformin appears to lower the risk of developing liver cancer in patients with type 2 diabetes, according to the results of a meta-analysis reported in the July issue of the Journal of Clinical Endocrinology and Metabolism.
However, “Further investigation, including...
Reuters Health • The Doctor's Channel Daily Newscast
Growth hormone maintains cognition in children with Prader-Willi syndrome
1:37 |
May 8, 2012
|
Endocrinology, Family Medicine, Medical Students, Nurses/NP/PA, Pediatrics, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – The decline in cognitive function in children with Prader-Willi syndrome can be stabilized with ongoing growth-hormone (GH) therapy, a Dutch team reports in the July issue of the Journal of Clinical Endocrinology and Metabolism.
“Furthermore, children with a greater deficit...
Reuters Health • The Doctor's Channel Daily Newscast
Sleeve gastrectomy better than medical therapy for obesity-related diabetes
1:41 |
Apr 19, 2012
|
Diabetes, Endocrinology, Gastroenterology, Reuters Health • The Doctor's Channel Daily Newscast, Surgery
NEW YORK (Reuters Health) – Sleeve gastrectomy leads to significant improvement or resolution of type 2 diabetes in morbidly obese patients, and is much more effective than intensive conventional medical therapy, confirms a comparative study of patients treated at the Centre for the Surgical-Medical...
Different modes of continuous glucose monitoring improve diabetes control
1:44
|
Apr 17, 2012
Cigarette smoking potentiates effects of clopidogrel in diabetics
1:36
|
Apr 6, 2012
Oral bisphosphonates linked to ocular side effects
1:17
|
Apr 4, 2012
Once-daily lixisenatide effective as monotherapy for DM2
1:38
|
Apr 2, 2012
Dapagliflozin helpful in type 2 diabetes inadequately controlled with insulin
1:53
|
Mar 22, 2012
High HbA1c in undernourished subjects may not indicate prediabetes
01:45
|
Mar 7, 2012
Exenatide once weekly remains superior to insulin glargine over long term
01:51
|
Mar 6, 2012
Risk of new-onset diabetes with niacin less than previously thought: study
01:45
|
Mar 5, 2012
Cabergoline combined with low-dose pegvisomant effective in acromegaly
01:35
|
Feb 27, 2012
Study suggests patients lose fat on diabetes drug dapagliflozin
01:45
|
Feb 21, 2012
Once-weekly taspoglutide effective for DM2 but development uncertain
1:33
|
Feb 15, 2012
Adrenal hyperplasia screening unreliable in preemies
1:47
|
Feb 9, 2012
Longer screening interval for retinopathy might be safe for some diabetics
1:37
|
Feb 6, 2012
Fenofibrate safe in type 2 diabetes and moderate renal impairment
1:31
|
Jan 18, 2012
Prevalence of prediabetes high in patients on antipsychotics
1:35
|
Jan 17, 2012
Continuous glucose monitoring does not improve glycemic control in children
1:40
|
Jan 17, 2012
Weekly sustained-release growth hormone as effective as daily dosing
2:00
|
Jan 3, 2012
Cirrhosis tied to increased risk of liver cancer in diabetics
1:36
|
Dec 26, 2011
High-dose human regular U-500 insulin may have longer duration of action
1:49
|
Nov 18, 2011
Insulin resistance not tied to atrial fibrillation
1:25
|
Nov 18, 2011
Vandetanib helpful in medullary thyroid cancer
1:36
|
Nov 9, 2011
Tight glycemic control does not curb heart failure risk in type 2 diabetes
1:31
|
Nov 8, 2011
Insulin sensitizers reduce lean mass loss associated with diabetes
2:03
|
Oct 13, 2011
Bariatric surgery improves cardiovascular risk profile
1:33
|
Oct 11, 2011
